{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T00:27:49Z","timestamp":1724891269935},"reference-count":7,"publisher":"Scientific Scholar","content-domain":{"domain":["nmji.in"],"crossmark-restriction":true},"short-container-title":["NMJI"],"abstract":"<jats:p>Bacille Calmette-Gu\u00e9rin (BCG) vaccine has been used increasingly in immunotherapy, including treatment of non-muscle-invasive bladder cancer, as an adjuvant therapy in metastatic prostate cancer and metastatic melanoma. However, systemic infection from inadvertent intravenous (instead of intravesical) injection is uncommon and can have systemic ramifications. We encountered 3 patients with disseminated <jats:italic>Mycobacterium bovis<\/jats:italic> infection that ensued after intravenous BCG injection.<\/jats:p>","DOI":"10.25259\/nmji_316_2022","type":"journal-article","created":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T07:07:53Z","timestamp":1724828873000},"page":"86-88","update-policy":"http:\/\/dx.doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Disseminated mycobacteriosis secondary to intravenous Bacille Calmette-Gu\u00e9rin (BCG) vaccine"],"prefix":"10.25259","volume":"37","author":[{"given":"HARSHDEEP HARSHAD","family":"ACHARYA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ANUPA","family":"THAMPY","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RAJIV","family":"KARTHIK","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PRISCILLA","family":"RUPALI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","published-online":{"date-parts":[[2024,8,26]]},"reference":[{"key":"10.25259\/NMJI_316_2022\/ref-1","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/s41585-018-0055-4","article-title":"Mechanisms of BCG immunotherapy and its outlook for bladder cancer","volume":"15","author":"Pettenati","year":"2018","journal-title":"Nat Rev Urol"},{"key":"10.25259\/NMJI_316_2022\/ref-2","article-title":"Patterns of antimicrobial susceptibility in Michigan wildlife and bovine isolates of Mycobacterium bovis","author":"Daly","year":"2016","journal-title":"J Vet Diagn Invest"},{"key":"10.25259\/NMJI_316_2022\/ref-3","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/0002-9343(90)90340-J","article-title":"Miliary tuberculosis: Rapid diagnosis, hematologic abnormalities, and outcome in 109 treated adults","volume":"89","author":"Maartens","year":"1990","journal-title":"Am J Med"},{"key":"10.25259\/NMJI_316_2022\/ref-4","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s12879-015-0944-6","article-title":"A systematic review of hepatic tuberculosis with considerations in human immunodeficiency virus co-infection","volume":"15","author":"Hickey","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.25259\/NMJI_316_2022\/ref-5","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.cld.2012.03.013","article-title":"Granulomatous liver disease","volume":"16","author":"Flamm","year":"2012","journal-title":"Clin Liver Dis"},{"key":"10.25259\/NMJI_316_2022\/ref-6","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/00005792-197203000-00004","article-title":"Miliary tuberculosis in the chemotherapy era: With a clinical review in 69 American adults","volume":"51","author":"Munt","year":"1972","journal-title":"Medicine (Baltimore)"},{"key":"10.25259\/NMJI_316_2022\/ref-7","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1097\/00005792-198009000-00003","article-title":"Late generalized tuberculosis: A clinical pathologic analysis and comparison of 100 cases in the preantibiotic and antibiotic eras","volume":"59","author":"Slavin","year":"1980","journal-title":"Medicine (Baltimore)"}],"container-title":["The National Medical Journal of India"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/nmji.in\/disseminated-mycobacteriosis-secondary-to-intravenous-bacille-calmette-gurin-bcg-vaccine\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/nmji.in\/disseminated-mycobacteriosis-secondary-to-intravenous-bacille-calmette-gurin-bcg-vaccine\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T07:07:58Z","timestamp":1724828878000},"score":1,"resource":{"primary":{"URL":"https:\/\/nmji.in\/disseminated-mycobacteriosis-secondary-to-intravenous-bacille-calmette-gurin-bcg-vaccine\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,26]]},"references-count":7,"alternative-id":["10.25259\/NMJI_316_2022"],"URL":"https:\/\/doi.org\/10.25259\/nmji_316_2022","relation":{},"ISSN":["2583-150X","0970-258X"],"issn-type":[{"value":"2583-150X","type":"electronic"},{"value":"0970-258X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,26]]},"article-number":"86"}}